am posting details for the InnovationWell Autumn Community of
Practice Meeting in October 2008 in Bryn Mawr, Philadelphia.
Compuational Biology is one of the key themes of this conference.
Please note that the deadline to apply for bursaries is July 31,
Innovation in Life Science & Healthcare Research and Product
InnovationWell Autumn Community of Practice Meeting October 14-17,
2008 Bryn Mawr College, Bryn Mawr, Philadelphia, USA
The InnovationWell program will be covering topics in systems biology,
computational biology, knowledge management, translational medicine,
metabolomics, and predictive toxicology. The eCheminfo program will be
covering topics in drug discovery informatics.
Abstracts (300-500 words) should be submitted to innovationwell -[at]-
douglasconnect.com or echeminfo -[at]- douglasconnect.com by 31 July
2008, and be accompanied by a short biography of the presenting author
(300-500 words). Abstracts approved by the scientific organizing
committee will be selected for scheduling on the conference program
and in meeting poster sessions. Authors will be notified of acceptance
as soon as a review of submitted materials takes place and at the
latest by 15 August 2008.
Bursary Awards will be used to support the attendance of a selection
of academic young investigators at the meeting and workshops.
Applicants can be working in any area of research related to drug
discovery & development at the postdoctoral, graduate student and
senior undergraduate levels.
To apply for the bursary please send an email with a) your abstract
and biography (300-500 words each), b) your CV of 1-2 pages, c) a
short description of your interests and career motivations(300-500
words) to innovationwell -[at]- douglasconnect.com or echeminfo -[at]-
douglasconnect.com by 31 July 2008.
The recipients of the bursary awards will be selected based on an
evaluation of the quality and innovation of the described research and
the potential positive impact of attendance at the meeting on their
research and career progress. Authors will be notified of acceptance
by 15 August 2008.
Keith Elliston (Genstruct), Debraj GuhaThakurta (Rosetta Inpharmatics,
Merck & Co.), Stephen W. Edwards (U.S. Environmental Protection
Agency), Paul McDonagh (Gene Network Sciences), Christopher M.L.S.
Bouton (Pfizer), James R. Brown (GlaxoSmithKline), John Wilbanks
(Creative Commons), Barry Bunin (Collaborative Drug Discovery),
Michael Liebman (Windber Research Institute), Jerry Wright (Johns
Hopkins Medical Institutions), Anastasia Christianson (AstraZeneca),
James Golden (Science Applications International Corporation), John
Speakman (National Cancer Institute), William Hayes (Biogen Idec),
Andrew McMurray (Harvard University), Eugene Clark (Partners
Healthcare), Alvin Berger (Metabolon), John Newman (USDA), Bruce
Kristal (Brigham and Women Hospital), Anton Hopfinger (University of
New Mexico), Heidi Einolf (Novartis), Yojiro Sakiyama (Pfizer), Olga
Obrezanova (BioFocus DPI, UK), Anthony E. Klon (Pharmacopeia), Artem
Cherkasov (University of British Columbia, Canada), Ann Richards (US
EPA), Curt Breneman (RPI),
Alex Tropsha (UNC), Barry Hardy (Douglas Connect), Weida Tong (FDA)
Pre-Conference Workshop, October 13.
Knowledge Management in R&D chaired by John Conway (Accelrys) and
Frank Hollinger (FRESH D